NUR77 Antibody [J10J24]

Catalog No.: F4786

    Application: Reactivity:
    • Lane 1: HeLa, Lane 2: HeLa (MG-132, 10µM, 6 h)
    1/

    当該製品は品切れ状态で、ごメールアドレスを教えていただければ、在庫があると、メールで顧客様に伝えます。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    60秒以上の露光(暴露)を推奨します。

    使用情報

    Dilution
    1:1000
    1:30
    1:500
    Application
    WB, IP, FCM
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    64 kDa 32 kDa,38 kDa,60-80 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール Jurkat cells (TPA, 40nM; A-23187, 2uM, 4 h); Jurkat cells (TPA, 40nM, A-23187, 2uM; MG-132, 10uM, 4 h); HeLa cells (MG-132, 10uM, 6h)
    ネガティブコントロール HeLa cells; Jurkat cells

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system. (Exposure time of at least 60s is recommended)

    Datasheet & SDS

    生物学的記述

    Specificity
    NUR77 Antibody [J10J24] detects endogenous levels of total NUR77 protein.
    タンパク質の局在
    細胞質、ミトコンドリア、細胞核
    Uniprot ID
    P22736
    Clone
    J10J24
    Synonym(s)
    GFRP1; HMR; NAK1; NR4A1; Nuclear receptor subfamily 4 group A member 1; Early response protein NAK1; Nuclear hormone receptor NUR/77; Orphan nuclear receptor HMR; Orphan nuclear receptor TR3; ST-59; Testicular receptor 3; Nur77
    Background
    NUR77 (NR4A1, TR3, NGFI-B) is an orphan nuclear receptor and immediate-early gene product that acts as a ligand-independent transcription factor rapidly induced by stress, growth factors, and apoptotic signals to regulate cell fate decisions in immunity, metabolism, and tumorigenesis. NUR77 has a canonical nuclear receptor architecture with an intrinsically disordered N-terminal A/B transactivation domain (AF-1) rich in phosphorylation sites, a central C-domain DNA-binding domain containing two zinc-finger motifs that recognize NBRE (AAAGGTCA) elements as a monomer or DR5 sites as RXR heterodimers, a flexible D-hinge region with nuclear localization signals, and a C-terminal E/F ligand-binding domain (aa 351–598) that lacks a classical hydrophobic pocket but supports AF-2 coactivator recruitment and homo/heterodimerization. Mechanistically, various kinases (ERK, JNK, PKC) phosphorylate the N-terminal domain to enhance transactivation and promote mitochondrial translocation, where NUR77 exposes a BH3-like motif to convert anti-apoptotic Bcl-2 into a pro-apoptotic conformer that releases cytochrome c and activates caspases. In the nucleus, NUR77 upregulates FasL, TRAIL, and TRAIL receptor expression to amplify extrinsic apoptosis, inhibits NF-κB p65 via direct interaction to suppress inflammation, and coactivates SREBP or PPARγ to balance lipogenesis and β-oxidation in metabolic tissues, while TCR-induced NUR77 enforces T-cell negative selection by sensitizing thymocytes to Bim-mediated apoptosis. NUR77 deficiency accelerates atherosclerosis through unchecked NF-κB-driven inflammation and foam cell formation, promotes autoimmunity by impairing T-cell apoptosis, and enhances chemical hepatocarcinogenesis. Overexpression or ligand activation suppresses tumor growth in prostate, lung, and ovarian cancers by restoring apoptosis.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください